Hook CC - Search Results

1

Etiologies of Extreme Thrombocytosis: A Contemporary Series.

Hsieh RW, Ravindran A, Hook CC, Begna KH, Ashrani AA, Pruthi RK, Marshall AL, Hogan W, Litzow M, Hoyer J, Oliveira JL, Vishnu P, Call TG, Al-Kali A, Patnaik M, Gangat N, Pardanani A, Tefferi A, Go RS. Hsieh RW, et al. Among authors: hook cc. Mayo Clin Proc. 2019 Aug;94(8):1542-1550. doi: 10.1016/j.mayocp.2019.01.041. Mayo Clin Proc. 2019. PMID: 31378229

2

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Mesa RA, Tefferi A, Elliott MA, Hoagland HC, Call TG, Schroeder GS, Yoon SY, Li CY, Gray LA, Margolin S, Hook CC. Mesa RA, et al. Among authors: hook cc. Br J Haematol. 2001 Jul;114(1):111-3. doi: 10.1046/j.1365-2141.2001.02883.x. Br J Haematol. 2001. PMID: 11472354 Free article. Clinical Trial.

3

Thalidomide treatment in myelofibrosis with myeloid metaplasia.

Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, Geyer SM, Tefferi A. Elliott MA, et al. Among authors: hook cc. Br J Haematol. 2002 May;117(2):288-96. doi: 10.1046/j.1365-2141.2002.03443.x. Br J Haematol. 2002. PMID: 11972510 Free article. Clinical Trial.

4

Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia.

Steensma DP, Hook CC, Stafford SL, Tefferi A. Steensma DP, et al. Among authors: hook cc. Br J Haematol. 2002 Sep;118(3):813-6. doi: 10.1046/j.1365-2141.2002.03695.x. Br J Haematol. 2002. PMID: 12181050 Free article.

5

Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.

Mueller PS, Hook CC, Hayes DL. Mueller PS, et al. Among authors: hook cc. Mayo Clin Proc. 2003 Aug;78(8):959-63. doi: 10.4065/78.8.959. Mayo Clin Proc. 2003. PMID: 12911044

6

Primer on medical genomics. Part XIII: Ethical and regulatory issues.

Hook CC, DiMagno EP, Tefferi A. Hook CC, et al. Mayo Clin Proc. 2004 May;79(5):645-50. doi: 10.4065/79.5.645. Mayo Clin Proc. 2004. PMID: 15132406 Review.

7

Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin.

Elliott MA, Wolf RC, Hook CC, Pruthi RK, Heit JA, Letendre LL, Tefferi A, Kaufmann SH, Mesa RA, Litzow MR. Elliott MA, et al. Among authors: hook cc. Leuk Lymphoma. 2004 Aug;45(8):1545-9. doi: 10.1080/10428190410001693588. Leuk Lymphoma. 2004. PMID: 15370205

8

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.

Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, Litzow MR. Behl D, et al. Among authors: hook cc. Leukemia. 2006 Jan;20(1):29-34. doi: 10.1038/sj.leu.2404032. Leukemia. 2006. PMID: 16281063 Clinical Trial.

9

The Terri Schiavo saga: the making of a tragedy and lessons learned.

Hook CC, Mueller PS. Hook CC, et al. Mayo Clin Proc. 2005 Nov;80(11):1449-60. doi: 10.4065/80.11.1449. Mayo Clin Proc. 2005. PMID: 16295025 Review.

10

Report of 255 clinical ethics consultations and review of the literature.

Swetz KM, Crowley ME, Hook C, Mueller PS. Swetz KM, et al. Mayo Clin Proc. 2007 Jun;82(6):686-91. Mayo Clin Proc. 2007. PMID: 17550748 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page